 |
|
Implication of microRNA as a potential biomarker of myocarditis
Jin-Hee Oh, Gi Beom Kim, Heeyoung Seok
Clin Exp Pediatr. 2022;65(5):230-238. Published online 2022 Mar 2 DOI: https://doi.org/10.3345/cep.2021.01802
|
|
Citations to this article as recorded by
 MicroRNAs as novel biomarkers for the diagnosis and treatment of pediatric diseases
Hwal Rim Jeong, Il Tae Hwang
Clinical and Experimental Pediatrics.2024; 67(3): 119. CrossRef Artificial intelligence and myocarditis—a systematic review of current applications
Paweł Marek Łajczak, Kamil Jóźwik
Heart Failure Reviews.2024;[Epub] CrossRef Liquid Biopsies Poorly miRror Renal Ischemia-Reperfusion Injury
Adaysha C. Williams, Vaishali Singh, Pengyuan Liu, Alison J. Kriegel
Non-Coding RNA.2023; 9(2): 24. CrossRef MicroRNAs in Myocarditis—Review of the Preclinical In Vivo Trials
Grzegorz Procyk, Olga Grodzka, Marcelina Procyk, Aleksandra Gąsecka, Katarzyna Głuszek, Małgorzata Wrzosek
Biomedicines.2023; 11(10): 2723. CrossRef Coronavirus disease 2019 and mRNA vaccines: what’s next – miRNA?
Joon Kee Lee, Heon-Seok Han
Clinical and Experimental Pediatrics.2022; 65(6): 302. CrossRef Integration of RNA molecules data with prior-knowledge driven Joint Deep Semi-Negative Matrix Factorization for heart failure study
Zhihui Ma, Bin Chen, Yongjun Zhang, Jinmei Zeng, Jianping Tao, Yu Hu
Frontiers in Genetics.2022;[Epub] CrossRef The Role of MicroRNAs in Myocarditis—What Can We Learn from Clinical Trials?
Olga Grodzka, Grzegorz Procyk, Aleksandra Gąsecka
International Journal of Molecular Sciences.2022; 23(24): 16022. CrossRef
|